parkinson glutathione oxidative ipsc crispr Frontiers CRISPR-Cas9-Based Technology and Its Relevance
CRISPR Cas9 Based Technology and Its Relevance to Gene Editing in Parkinson's Disease Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024 Journal of Molecular Medicine Springer Nature Link The glutathione system in Parkinson's disease and its progression ScienceDirect Patient Specific iPSC Derived Astrocytes Contribute to Non Cell Autonomous Neurodegeneration in Parkinson's Disease ScienceDirect Frontiers Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy
Pay in 4 interest-free payments of $5.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




